PATENT CLAIM ANALYSIS

Application Number: 15880725
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "016900"]

Abstract:
An object of the present invention is the use of Irisin for the treatment and/or prevention of osteoporosis. In particular, the present invention refers to the use of recombinant irisin for the treatment and/or prevention of osteoporosis. A method for preventing and/or treating osteoporosis by administering an effective amount of irisin to a subject, is provided.

Claim (Index 8):
A method of preventing and/or treating osteoporosis, said method comprising administering a composition including an effective amount of irisin to a subject in need thereof.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 86.0
- Lexical Diversity: 1.79412
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11684996', '11098894', '11216511', '09647278', '10340484']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7712906591017304
- 35 USC 102 Novelty (BERT): 0.5139349421770619
- Combined Prediction Score: 0.7455550874092637
- Mean Citation Score: 273.42699400000004
- Max Citation Score: 282.7181
- Similarity Product: 181.49816724327803

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test